Genome analysis of collagen disease in MRL/lpr mice: Polygenic inheritance resulting in the complex pathological manifestations

International Journal of Cardiology

Volumn 75, Issue SUPPL. 1, 2000, Pages

  Nose, Masato ^a   Terada, Miho ^a   Nishihara, Miyuki ^a   Kamogawa, Junji ^a   Miyazaki, Tatsuhiko ^a   Qu, Wei Min ^a   Mori, Shiro ^b   Nakatsuru, Syuichi ^c  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KAN Research Institute ^*  (Japan)

Author keywords

Animal model; Arthritis; Glomerulonephritis; Mouse genomics; Sialoadenitis; Vasculitis

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; CHROMOSOME ANALYSIS; COLLAGEN DISEASE; GENE LOCUS; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC RECOMBINATION; GENOME; GLOMERULONEPHRITIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; MULTIFACTORIAL INHERITANCE; NONHUMAN; POLYARTERITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIALOADENITIS; SJOEGREN SYNDROME;

EID: 0034739070     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00191-1     Document Type: Article

References (32)

1. Klemperer P, Pollack AD, Baehr G. Diffuse collagen disease. Acute disseminated lupus erythematosus and diffuse scleroderma. J Am Med Assoc 1942; 119:331-2.
2. Silver M, Berkowitz S, Johnston A, Steinbrocker O. The 'overlap syndrome' (Rheumatoid arthritis with features of systemic lupus): An 8-year follow-up with 2 postmortems. Arthritis Rheum 1962;5:321.
3. Murphy ED, Roths JB. Autoimmunity and lymphoproliferation: Induction by mutant gene lpr, and acceleration by a male-associated factor in strain BXSB mice. In: Rose NR, Bigazzi PE, Werner NL, editors, Genetic control of autoimmune disease, New York: Elsevier North Holland Inc, 1978, pp. 207-20.
4. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-215.
5. Izui S, Eisenberg RA. Circulating anti-DNA-rheumatoid factor complexes in MRL/1 mice. Clin Immunol Immunopathol 1980;15:536-51.
6. Harper JM, Thiru S, Lockwood CM, Cooke A. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: a spontaneous model for human microscopic angitis. Eur J Immunol 1998;28:2217-26.
7. Moyer CF, Strandberg DJ, Reinish CL. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice: A histologic and immunocytochemical analysis. Am J Pathol 1987; 127:229-42.
8. Morse III HC, Davidson WF, Yetter RA, Murphy ED, Roths JB, Coffman RL. Abnormalities induced by the mutant gene lpr: Expansion of unique lymphocyte subset. J Immunol 1982;129:2612-5.
9. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-7.
10. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron if the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993;90:1756-60.
11. + T cells. Nature 1995;376:181-4.
12. + lymphocytes delete activated macrophages through the Fas/ APO-1 antigen pathway. Proc Natl Acad Sci USA 1995;92:11225-9.
13. Dixon FJ, Theofilopoulos AN, McConahey PJ, Prud'Homme GJ. Systemic lupus erythematosus. Prog Immunol 1983;5:111 5.
14. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985;37:269-90.
15. Nose M, Nishimura M, Kyogoku M. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis. Am J Pathol 1989;135:271-80.
16. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 1991;147:515-20.
17. Nose M. Genetic basis of vasculitis in lupus mice. In: Tanabe T, Yoshiki T, Okayasu T, editors, Intractable vasculitis syndrome, Sapporo: Hokkaido University Press, 1993, pp. 145-54.
18. Nose M, Nishimura M, Ito MR, Itoh J, Shibata T, Sugisaki T. Arteritis in a novel congenic strain of mice derived from MRL/lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody production. Am J Pathol 1996;149:1763-9.
19. Nakatsuru S, Terada M, Nishihara M, Kamogawa J, Miyazaki T, Qu WM, Morimoto K, Yazawa C, Ogasawara H, Abe Y, Fukui K, Ichien G, Ito RM, Mori S, Nakamura Y, Nose M. Genetic dissection of the complex pathological manifestations of collagen disease in MRL/lpr mice. Pathol Int 1999;49:974-82.
20. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Gen 1995;11:241-7.
21. Wang Y, Nose M, Kamoto T, Nishimura M, Hiai H. Host modifier genes affect mouse autoimmunity induced by the lpr gene. Am J Pathol 1997;151:1791-8.
22. Anderson SJ, Levin SD, Perlmutter RM. Protein tyrosine kinase p56 (lck) controls allelic exclusion of T-cell receptor β chain genes. Nature 1993;365:552-4.
23. Rother K. Hereditary deficiencies in man: Summary of reported deficiencies. Prog Allergy 1986;39:202-11.
24. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996;85:311-8.
25. Lynn AH, Kwoh CK, Venglish CM, Aston CE, Chakravarti A. Genetic epidemiology of rheumatoid arthritis. Am J Hum Genet 1995;57:150-9.
26. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987;40:1-14.
27. Rigby AS, Voelm L, Silman AJ. Epistatic modeling in rheumatoid arthritis: an application of the Risch theory. Genet Epidemiol 1993;10:311-20.
28. Yanagi K, Haneji N, Hamano H, Takahashi M, Higashiyama H, Hayashi Y In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice. Cell Immunol 1996;168:243-50.
29. Takahashi M, Mimura Y, Hamano H, Haneji N, Yanagi K, Hayashi Y Mechanism of the development of autoimmune dacryadenitis in the mouse model for primary Sjögren's syndrome. Cell Immunol 1996;170:54-62.
30. McCartney-Francis NL, Mizel DE, Redman RS, Frazier-Jessen M, Panek RB, Kulkarni AB, Ward JM, McCarthy JB, Wahl SM. Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides. J Immunol 1996;157:1305-12.
31. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997;276:604-7.
32. Tzioufas AG, Skopouli FN, Boumba D, Moutsopoulos HM. Vasculitis in primary Sjögren's syndrome. In: Ansell BM, Bacon PA, Lie JT, Yazici H, editors, The vasculitides: science and practice, London: Chapman & Hall Medical, 1996, pp. 277-82.